Search API

UTI
RECCE® 327 at 4,000 mg intravenously at a fast infusion rate of 20-minutes
polio
WPV1 poliovirus eliminated in Malawi and Mozambique
measles vaccine
51 countries confirm measles outbreaks in 2024
Ebola vaccine
Zaire Ebolavirus vaccines and antibody therapies are approved in 2024
dengue vaccine
Dengue vaccines are available in 2024
ACI-24.060 is an anti-Abeta active immunotherapy candidate targeting Alzheimer's disease
vaccine
Protein based COVID-19 vaccine producer Novavax partners with Sanofi
Dengue vaccine
Dengue vaccines are approved in May 2024
rabies vaccine
Pika Rabies vaccine candidate targets one-week human rabies regimen
malaria
Malaria vaccines are unavailable in the United States